Open AccessDual-Targeted Antibody Offers Positive Outcomes for Non-Hodgkin Lymphoma
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000653352.65501.9d
Subject(s) - lymphoma , medicine , b cell , cd20 , oncology , cancer , antibody , rituximab , cancer research , immunology